|
PRKAA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12250000405822E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29690003181082E-09 |
| Normal-vs-Stage2 |
2.804300E-03 |
| Normal-vs-Stage3 |
3.921600E-03 |
| Normal-vs-Stage4 |
5.358200E-04 |
| Stage1-vs-Stage2 |
3.601600E-01 |
| Stage1-vs-Stage3 |
1.471200E-01 |
| Stage1-vs-Stage4 |
7.409400E-01 |
| Stage2-vs-Stage3 |
7.743600E-01 |
| Stage2-vs-Stage4 |
7.468800E-01 |
| Stage3-vs-Stage4 |
5.831200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.48829995391975E-09 |
| Normal-vs-AfricanAmerican |
1.211199999962E-06 |
| Normal-vs-Asian |
2.224900E-03 |
| Caucasian-vs-AfricanAmerican |
6.920600E-01 |
| Caucasian-vs-Asian |
9.429000E-01 |
| AfricanAmerican-vs-Asian |
8.334000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.69289948515461E-10 |
| Normal-vs-Female |
3.101300E-03 |
| Male-vs-Female |
7.219400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.05249999998924E-06 |
| Normal-vs-Extreme_Weight |
2.1810999673022E-09 |
| Normal-vs-Obese |
4.14049999997168E-06 |
| Normal-vs-Extreme_Obese |
4.51570000004065E-06 |
| Normal_Weight-vs-Extreme_Weight |
5.044400E-01 |
| Normal_Weight-vs-Obese |
5.010800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.016000E-01 |
| Extreme_Weight-vs-Obese |
1.240980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.316600E-01 |
| Obese-vs-Extreme_Obese |
1.918630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.601290E-03 |
| Normal-vs-Age(41-60Yrs) |
2.14649999996652E-06 |
| Normal-vs-Age(61-80Yrs) |
2.1705004460415E-10 |
| Normal-vs-Age(81-100Yrs) |
2.10720000004549E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.188000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.400040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.236500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.195870E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.856640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.102200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.33849994923929E-09 |
| Normal-VS-Type2 PRCC |
2.52970000502728E-08 |
| Normal-VS-KIRP CIMP |
4.025500E-04 |
| Normal-VS-Unclassified PRCC |
4.763000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.949600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.002600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.165050E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.570200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.487840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.132400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.63229999914105E-08 |
| Normal-vs-N1 |
9.363100E-04 |
| Normal-vs-N2 |
1.039980E-03 |
| N0-vs-N1 |
1.232810E-01 |
| N0-vs-N2 |
3.089800E-01 |
| N1-vs-N2 |
2.231600E-02 |
|
|
